# Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

> **NCT04399876** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Brigham and Women's Hospital** · enrollment: 35 (estimated)

## Conditions studied

- Prostate Cancer
- Radical Prostatectomy

## Interventions

- **COMBINATION_PRODUCT:** Microdevice

## Key facts

- **NCT ID:** NCT04399876
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2020-06-22
- **Primary completion:** 2027-08-01
- **Final completion:** 2027-11-01
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04399876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04399876, "Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT04399876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*